ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is China Shineway Pharmaceutical Group Ltd. ?
1
Poor long term growth as Operating profit has grown by an annual rate 8.54% of over the last 5 years
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is China Shineway Pharmaceutical Group Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
China Shineway Pharmaceutical Group Ltd.
12.4%
0.10
25.23%
Hang Seng Hong Kong
8.76%
0.45
19.63%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.19%
EBIT Growth (5y)
8.54%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.82
Sales to Capital Employed (avg)
0.54
Tax Ratio
26.68%
Dividend Payout Ratio
37.03%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
48.03%
ROE (avg)
10.55%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
0.89
EV to EBIT
0.52
EV to EBITDA
0.42
EV to Capital Employed
0.28
EV to Sales
0.10
PEG Ratio
NA
Dividend Yield
0.02%
ROCE (Latest)
53.68%
ROE (Latest)
10.43%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend10What is working for the Company
OPERATING CASH FLOW(Y)
Highest at HKD 2,740.75 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -89.69 %
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
CASH AND EQV(HY)
Highest at HKD 8,426.77 MM
PRE-TAX PROFIT(Q)
At HKD 541.46 MM has Grown at 75.97%
NET PROFIT(Q)
At HKD 367.06 MM has Grown at 58.43%
-2What is not working for the Company
NET SALES(Q)
Lowest at HKD 1,623.23 MM
Here's what is working for China Shineway Pharmaceutical Group Ltd.
Operating Cash Flow
Highest at HKD 2,740.75 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Debt-Equity Ratio
Lowest at -89.69 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Pre-Tax Profit
At HKD 541.46 MM has Grown at 75.97%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (HKD MM)
Net Profit
At HKD 367.06 MM has Grown at 58.43%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
Cash and Eqv
Highest at HKD 8,426.77 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Depreciation
At HKD 84.22 MM has Grown at 6.05%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for China Shineway Pharmaceutical Group Ltd.
Net Sales
Lowest at HKD 1,623.23 MM and Fallen
In each period in the last five periodsMOJO Watch
Near term sales trend is very negative
Net Sales (HKD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
